CHRS
Coherus BioSciences Inc
1.30$
-5.1%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -3.4% | +532.8% | -99.2% | +0.0% | +22,783.7% | +33.6% | -31.4% | -35.4% | +21.9% | +3.8% | -84.2% | |
| – | +171.9% | +19.6% | -36.9% | -98.0% | +427.9% | +120.6% | +52.9% | +21.7% | +126.9% | -26.1% | -84.9% | |
| – | – | – | – | – | – | +29.3% | -38.6% | -47.6% | -30.3% | +52.1% | -83.6% | |
| – | +172.4% | +19.4% | -36.2% | -32.1% | -14.6% | +51.6% | +154.3% | -45.1% | -45.1% | -14.7% | +12.5% | |
| – | +105.2% | +43.1% | +38.2% | +32.1% | +40.7% | +2.1% | +19.0% | +16.7% | -7.1% | -20.1% | -27.9% | |
| – | +160.1% | +22.9% | -23.6% | -12.5% | +13.1% | +21.9% | +89.1% | -25.3% | -24.2% | -13.4% | -21.9% | |
| – | – | – | – | – | – | +45.1% | -268.8% | – | – | – | – | |
| – | -99.2% | +24,081.8% | +19.7% | +1.4% | +81.8% | +20.3% | +8.5% | +41.4% | +24.8% | -33.0% | -66.9% | |
| – | – | – | – | – | – | +46.3% | -311.6% | – | – | – | -742.4% | |
| – | – | – | +1,339.0% | -50.3% | -37.3% | +17.7% | +455.1% | +81.4% | -101.1% | – | -1,267.5% | |
| – | – | – | – | – | – | +47.2% | -317.1% | – | – | – | -697.4% | |
| – | – | – | – | – | – | +45.8% | -261.1% | – | – | – | -379.3% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.